VuEssence develops molecular diagnostic solutions for stroke, using gene expression blood tests and machine learning to help clinicians assess patients with suspected stroke. [1]
The company was founded in 2010 by Maha Sallam, who serves as president, and is based in Odessa, Florida. It is working toward a blood test that returns stroke-specific gene expression results in under 15 minutes, with a long-term goal of a portable device for ambulances. It has worked with USF Health Neurology on a pilot study of its stroke test. [2]